Table 2.

Summary of the most common reported treatment-related adverse events in the CAPAGEC trial

	Number of adverse events	Number of patients (%)	Grade of events
Non hematologic adverse event
Hand-foot syndrome	21	11 (55)	1, 2, 3
Diarrhea	9	6 (30)	1, 2, 3
Fatigue	8	8 (40)	1, 2, 3, 4
Nausea	4	4 (20)	1, 2
Vomiting	3	3 (15)	1, 2
Abdominal pain	3	3 (15)	1, 2
Mucositis	3	2 (10)	1, 3
Dysgeusia	2	2 (10)	1
Paresthesia	3	1 (5)	2, 3
Anorexia	1	1 (5)	2
Hematologic adverse event
Anemia	5	3 (15)	1, 2, 3
Neutropenia	1	1 (5)	1
Thrombopenia	3	1 (5)	1, 2